Table 1.
Patient demography and details of studies and in the systematic review.
| Author | Duration | Region | Sample |
Age |
Sex |
Comorbidities (N) |
Mortality (%)‡ | |||
|---|---|---|---|---|---|---|---|---|---|---|
| (N) | (years) | (M/F) | Hypertension | DM | Smoking | CHF | ||||
| Zhou et al | Dec 29–31 Jan | China | 191 | 56 (46–67) | 119/72 | 58 | 36 | 11 | 44 | 28 |
| Chen et al | Jan 13 – Feb 12 | China | 274 | 62 (44–70) | 171/103 | 93 | 47 | 12 | 01 | 41 |
| Inciardi et al | Mar 04 – Mar 25 | Italy | 99 | 68.5 | 80/19 | 63 | 18 | 12 | 21 | 26 |
| Du et al | Jan 09 – Feb 15 | China | 85 | 65.8 ± 14.2 | – | 32 | 19 | NA | NA | 100 |
| Wang D., et al | Till Feb 10 | China | 107 | 51 (36–55) | 57/50 | 26 | 11 | NA | NA | 18 |
| Aggarwal et al | Mar 01 – April 04 | U.S. | 16 | 67 (38–95) | 12/4 | 09 | 05 | NA | 04 | 50 |
| Cao et al | Jan 03 – Feb 01 | China | 102 | 54 (37–67) | 53/49 | 28 | 11 | NA | NA | 16 |
| Shi et al | Jan 01 – Feb 23 | China | 671 | 63 (50–72) | 322/349 | 199 | 97 | NA | 22 | 9 |
| Wang L., et al | Jan 01 – Mar 05 | China | 339 | 69 (65–76) | – | 138 | 54 | NA | 58 | 19 |
| He et al | Feb 03 – Feb 24 | China | 54 | 68 | 34/20 | 24 | 13 | NA | NA | 48 |
| Huang et al∗ | – | China | 41 | 49 (41–68) | 30/11 | 06 | 08 | 03 | NA | 15 |
| Wang D., et al∗ | Jan 01 – Feb 03 | China | 138 | 56 (42–68) | 75/63 | 43 | 14 | NA | NA | 4.3 |
| Petrilli et al∗ | Mar 01 – April 08 | U.S. | 2729 | 64 | 1672/1057 | 1693 | 950 | 141 | 349 | 24 |
| Yang et al∗ | Jan 28 – Feb 12 | China | 136 | 56 (44–64) | 66/70 | 36 | 20 | NA | NA | 17 |
| Hu et al∗ | Jan 08 – Mar 10 | China | 323 | 61 (23–91) | 152/145 | 95 | 36 | 38 | NA | 11 |
| Deng et al∗ | Jan 06 - Mar 20 | China | 112 | 65 (49–70.8) | 57/55 | 36 | 19 | NA | NA | 12.5 |
| Wan et al∗ | Feb 08 – till end | China | 135 | 47 (36–55) | 73/62 | 13 | 12 | 09 | NA | 0.7 |
| Lu et al∗ | – | China | 265 | NA | NA | 52 | 21 | NA | NA | 0.38 |
| Han et al∗ | Feb 01 – Feb 18 | China | 47 | 65 (31–87) | NA | 18 | 07 | 07 | NA | NA |
| Peng et al∗ | Jan 20 – Feb 15 | China | 112 | 62 (55–67) | 53/49 | 92 | 23 | NA | 40 | 15 |
Descriptive values are represented as (n) and age as Mean ± standard deviation or Median (interquartile range).
Studies marked with asterisk (∗) compared outcomes in severe and non-severe cases of COVID-19; rest of the studies reported variables for survivors and non-survivors. CHF: Congestive Heart Failure; DM: Diabetes Mellitus; NA: Not available.
‡Mortality (%) numbers are rounded-off to the closest integer value.